Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.37
Dec. 09, 2025 09:25:00- Change 0.0038 (1.02703%)
- Volume 24,536
- Today's Open 0.3778
- Previous Close 0.37
- Today's High 0.38
- Today's Low 0.3702
- 52 Week High 4.3
- 52 Week Low 0.281